Leadership

Mary Duseau

President

Mary joins Molecular Devices with more than 25 years of experience in the Life Science Market holding roles of increasing responsibility in sales, marketing and business management.

Prior to joining Molecular Devices, she served as Senior Vice President, Commercial Management at Leica Biosystems, a Danaher company. Before joining Danaher, Mary was CEO and President for Roka Bioscience and prior to this, Senior Vice President, Sales for Andor Technologies and Global Vice President, Sales and Marketing for PerkinElmer. Additionally, at PerkinElmer, she held the role of Business Unit Leader, Imaging and Detection, focused in the Drug Discovery and Development market.

She holds a BS in Biochemistry, from the University of Massachusetts.

Jaison Battle

Vice President, Chief Financial Officer

As CFO, Jaison oversees all the company’s financial functions. Jaison joined Molecular Devices in January of 2022 bringing nearly 20 years of global financial leadership experience leading global manufacturing and consumer products businesses.

Prior to joining Molecular Devices, Jaison served as Vice President and CFO of DESTACO, an operating company of Dover Corporation, a global manufacturer of high-performance automation and work holding solutions where he oversaw the finance and IT functions of the company. Before that Jaison held progressive finance, operating and regional leadership roles at Rockwell Automation and Harley-Davidson. Jaison began his career in public accounting as an auditor at Ernst & Young (“EY”).

Jaison is a CPA and holds master’s degrees in both Accounting and Business Administration from the McIntyre School of Commerce at the University of Virginia and Harvard Business School. He holds a Bachelor of Arts in Business Administration from Whittier College.

David Micha

Vice President, Commercial

David Micha assumed the role of Vice President, Global Danaher Business Systems in May of 2020. He joined Molecular Devices in 2002 in a sales role and delivered solutions for researchers from across the company’s life sciences portfolio. David moved into sales management in 2010, and progressed through a series of leadership roles with increasing responsibilities across North America. Also, in 2010 David became Molecular Devices’ first commercially focused DBSL. In this aspect of his role he focused on the implementation of funnel management, visual management, and commercial problem solving across the North American and European sales organizations. In 2015 David became Molecular Devices’ first commercial operations leader and constructed a team to drive above market growth via the continuous improvement of sales and marketing processes.

Prior to joining Molecular Devices David worked at MWG Biotech and Marsh BioProducts. He also held research positions at the University of Rochester and the Guthrie Research Foundation. David earned a BS in Cell & Developmental Biology from the University of Rochester (NY). He is also a graduate of the American Management Association’s Operation Enterprise, and Danaher’s Maximizing Leadership Potential program.

Daniel Kang

General Counsel, Phenomenex & Molecular Devices

Daniel Kang has served as General Counsel of Molecular Devices, Phenomenex, and IDBS since April 2024 where he is responsible for overseeing legal affairs, providing guidance on corporate governance, negotiating contracts, and ensuring legal and regulatory compliance within the organizations. Daniel joined Phenomenex in January 2013 as legal counsel and was a critical member of the leadership team of Phenomenex in its preparation for its acquisition by Danaher in November 2016. Thereafter, he led the legal and compliance workstream for Phenomenex in its transition to Danaher.

Prior to Danaher, he worked at a boutique firm specializing in representing Asian companies in the United States, focusing on corporate matters and civil litigation.

Daniel has a BA in Politics from Occidental College and a JD from Chicago Kent College of Law.

Celeste Glazer

Vice President Global Marketing and Product Management

Celeste Glazer is Molecular Devices’ Vice President Global Marketing and Product Management reporting to President Susan Murphy, and member of the company’s executive leadership team.

Glazer has over 11 years of marketing and people management experience, including seven at Molecular Devices where she’s helped the company consistently drive global, double digit growth in new opportunity creation through multitouch marketing programs. A scientist herself, Glazer understands how to effectively differentiate Molecular Devices’ innovative bioanalytical solutions for protein and cell biology, while best addressing customer needs around life science research, pharmaceutical and biotherapeutic development.

Prior to Molecular Devices, Glazer held various marketing, product management and scientific positions such as applications scientist at Labcyte Inc. in Sunnyvale, Calif.; sales, product manager and marketing manager at FUJIFILM Wako Diagnostics U.S.A. Corporation in Mountain View, California.

Glazer graduated with a master’s degree in biology from Boston College and a bachelor’s degree in Biology from Santa Clara University. She’s authored four published scientific articles and is also an inventor named on the issued patent, “Continuous and NonContinuous Flow Bioreactor."

Dean Ding

Vice President, Global Operations

Dean joined Molecular Devices in June 2010 and was appointed Vice President of Global Operations in Apr.2017. Prior to his current role, he was the General Manager of Molecular Devices’ Shanghai, China plant. Dean has held multiple manufacturing leadership and General Manager roles in companies like General Electric, PerkinElmer, Donaldson and Siemens. He holds a BA in Mechanical Engineering from East China University of Science & Technology, and a Master’s degree in Industrial & Systems Engineering from National University of Singapore.

Dan Green

Vice President of Research and Development

Dan was appointed Vice President of R&D in June of 2020. He previously served as the Senior Director of BioImaging R&D since September of 2018 and Senior Director of Software since April of 2015. He has been with Molecular Devices and its predecessor companies since 1988, when he joined Universal Imaging Corporation as a software developer. Since then he has held a variety of technical and leadership roles of increasing responsibility. Dan holds a MS in Computer Science from the University of Illinois at Urbana-Champaign, and a BA from Cornell University, Ithaca NY

Shantanu Dhamija

Vice President of Strategy and Innovation

Shan joined Molecular Devices in April 2021 as Vice President of Strategy and Innovation to lead strategic planning and inorganic growth initiatives. He comes from Leica Biosystems, a Danaher company, where he started in 2014 as Director of Strategy and Market Analytics and was responsible for Strategic Planning, Mergers and Acquisitions (M&A) market work, and Market Intelligence. In 2017, his responsibilities evolved from driving commercial strategy and commercial process improvement to leading a 35-person Customer Care and Inside Sales group. Leveraging the Danaher Business System, he drove double-digit reductions in customer service order rework and established Inside Sales as a $80M channel, while helping increase his team’s engagement by nearly 70 percent.

Prior to Danaher, Shan was a part of Deloitte Consulting's Healthcare and Life Sciences Strategy and M&A practice. He earned his MBA and graduate degrees in Electrical and Biomedical Engineering from the University of Michigan, Ann Arbor, and his bachelor’s degree in Electrical Engineering from the University of Delhi, India.

Krishnapal Solanki

Vice President, DBS

As a Vice President - DBS, Krishnapal oversees all the continuous improvement effort globally across all the functions. Krishnapal Joined Molecular Devices in November 2021 bringing over 13 years of experience leading various functions across 3 different Danaher operating companies.

Krishnapal’s Danaher journey started as a customer (life science research) which later converted into a Danaher associate at Leica Microsystems as a Sr. Field Service Engineer and worked in a variety of progressive roles such as a Regional Supervisor of Field Service Operations, Growth Manager for the Americas, Sr Manager Sales & Marketing at Cepheid and most recently Director of DBS Innovation at Molecular Devices . Krishnapal is proficient and certified in Danaher process improvement tools like DM/VM, Funnel Management and PSP and has facilitated and led Kaizen workshops for cross functional teams at various Danaher opcos. His work expertise includes installing and maintaining all 3 DBS engines (Commercial, Innovation and Service) to drive over all organizational growth. Krishnapal is also involved in DE&I activities and been a Members Engagement Lead at Asian Descent + Friends ARG at Danaher from 2021-2022.

Krishnapal holds Master of Science degree Biomedical Engineering from UT Arlington and SW Medical Center Dallas. He holds Bachelor of Engineering degree in Biomedical Engineering from India.

Lakshmi Sailaja Eleswarapu

Vice President, IT

As Vice President of IT for SCIEX, Molecular Devices, and Danaher Life Sciences, Lakshmi Eleswarapu champions global IT strategy, fostering technological innovation and organizational excellence. Her role extends to supporting the Danaher Life Sciences Innovation Group (LSIG) commercial team and contributing to the L1 team at Molecular Devices. Her tenure includes significant achievements in business transformation, M&A IT integrations, and diversity initiatives. Lakshmi's career spans 26 years in IT, with the last 16 years dedicated to Danaher, positioning her to drive future innovation and growth.

Lakshmi holds a Bachelor’s in Mathematics with Honors from SSSIHL University (India) and a Master’s in Computer Applications from Osmania University (India).